ORGO - Organogenesis Holdings Inc - Ordinary Shares - Class A
IEX Last Trade
2.875
-0.025 -0.870%
Share volume: 375,129
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.90
-0.03
-0.86%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-09 | 2024-02-29 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 456.357 M | 457.272 M | 449.359 M | 446.107 M | 450.313 M | 462.647 M | 460.025 M | 458.481 M | |
| Current Assets | 231.543 M | 230.526 M | 222.609 M | 216.822 M | 216.435 M | 225.573 M | 225.044 M | 227.167 M | |
| Inventories | 23.235 M | 24.683 M | 24.783 M | 25.539 M | 25.364 M | 27.905 M | 28.253 M | 27.694 M | |
| Other Current Assets | 6.540 M | 4.707 M | 5.086 M | 9.847 M | 7.948 M | 9.567 M | 10.454 M | 13.979 M | |
| Short Term Investments | 6.540 M | 4.707 M | 5.086 M | 9.847 M | 7.948 M | 9.567 M | 10.454 M | 13.979 M | |
| Total Receivables | 88.824 M | 93.115 M | 89.450 M | 92.021 M | 93.615 M | 89.276 M | 81.999 M | 96.148 M | |
| Current Cash | 112.279 M | 107.250 M | 102.478 M | 88.694 M | 88.917 M | 98.226 M | 103.840 M | 88.626 M | |
| Total Non-current Assets | 224.814 M | 226.746 M | 226.750 M | 229.285 M | 233.878 M | 237.074 M | 234.981 M | 231.314 M | |
| Property Plant Equipment | 93.292 M | 97.012 M | 102.463 M | 106.637 M | 111.825 M | 117.503 M | 116.228 M | 114.245 M | |
| Other Assets | 1.665 M | 1.589 M | 1.520 M | 1.463 M | 1.393 M | 1.321 M | 5.990 M | 6.709 M | |
| Intangible Assets | 23.231 M | 22.010 M | 20.789 M | 19.560 M | 18.330 M | 17.101 M | 15.871 M | 14.970 M | |
| Goodwill | 28.772 M | 28.772 M | 28.772 M | 28.772 M | 28.772 M | 28.772 M | 28.772 M | 28.772 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 456.357 M | 457.272 M | 449.359 M | 446.107 M | 450.313 M | 462.647 M | 460.025 M | 458.481 M | |
| Total liabilities | 201.972 M | 200.944 M | 183.690 M | 182.406 M | 179.031 M | 185.782 M | 181.362 M | 180.451 M | |
| Total current liabilities | 88.230 M | 89.273 M | 75.023 M | 76.076 M | 73.455 M | 81.482 M | 80.509 M | 82.799 M | |
| Accounts Payable | 36.373 M | 37.952 M | 32.330 M | 30.310 M | 27.390 M | 26.784 M | 30.724 M | 23.230 M | |
| Other liabilities | 1.073 M | 1.090 M | 1.122 M | 1.145 M | 1.190 M | 1.191 M | 1.213 M | 1.242 M | |
| Current long term debt | 3.596 M | 5.004 M | 4.538 M | 5.009 M | 5.689 M | 6.657 M | 6.567 M | 6.592 M | |
| Long term debt | 68.969 M | 67.600 M | 66.231 M | 64.860 M | 63.891 M | 64.283 M | 62.633 M | 60.975 M | |
| Other liabilities | 1.073 M | 1.090 M | 1.122 M | 1.145 M | 1.190 M | 1.191 M | 1.213 M | 1.242 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 254.385 M | 256.328 M | 265.669 M | 263.701 M | 271.282 M | 276.865 M | 278.663 M | 278.030 M | |
| Common stock | 129.636 M | 130.903 M | 130.953 M | 131.084 M | 131.293 M | 131.312 M | 131.236 M | 131.862 M | |
| Retained earnings | -53.002 M | -52.787 M | -45.301 M | -48.885 M | -43.569 M | -40.402 M | -40.971 M | -43.071 M |